Thursday, 04 July 2024

MoU Signed Between the University of Kelaniya and Shree Dhootapapeshwar Limited, India

A Memorandum of Understanding (MoU) was signed between the University of Kelaniya and Shree Dhootapapeshwar Ltd from India to conduct research on “Rasaushdis” (Herbo mineral drugs), on the 12th of September 2023 at the Senate Hall of the University of Kelaniya.

The main objective of this MoU is to promote international agreement, scholarly collaboration, cultural interaction, and friendship by supporting educational, professional, and cultural activities among two parties. Accordingly, joint research activities, participation in seminars, and academic meetings, and organizing joint conferences/seminars/workshops are some of the activities organized through the MOU. Members of the Department of Chemistry are planning to carry out research activities and organize seminars, and conferences in collaboration with Shree Dhootapapeshwar Ltd, India.  

Mr. Ranjit Puranik, Managing Director of Shree Dhootapapeshwar Ltd, Mumbai, India was the chief guest of the event.

The event was graced by Senior Prof. Nilanthi De Silva, Vice Chancellor of the University of Kelaniya, Senior Prof. Sudath Kalingamudali, Dean of the Faculty of Science, Senior Prof. Kapila Seneviratne, Dean of the Faculty of Graduate Studies, Prof. Jeewantha Premaratne, Head of the Department of Chemistry, Senior Prof. Priyani Paranagama, Chair of Chemistry and Coordinator of the research team, Prof. Nimanthi Jayathilaka (member of the research team), Prof. Suranga Wickramarachchi (member of the research team) from the University of Kelaniya Dr. Dammika Abeygunawardana, Commissioner of Ayurveda, Department of Ayurveda, Ministry of Health, and Mr. Ranjit Puranik (Chairman and Managing Director of SDL), Dr. Mukesh Chawda(Senior Manager Healthcare Services (SDL and Solumiks)), Dr. Ketan Bhapkar (Manager Exports), Mr. P. Vasudevan (Owner of AVH Distributors), Mr. Annesly Michael (Director of AVH Distributors) from Shree Dhootapapeshwar Ltd.

Newsletter

Subscribe to our newsletter. Don’t miss any news or stories.

We do not spam!